Literature DB >> 16510032

Current approaches to the diagnosis and treatment of cholangiocarcinoma.

Santosh B Reddy1, Tushar Patel.   

Abstract

Malignancies arising from biliary tract epithelia, or cholangiocarcinoma, are rare tumors that have a poor prognosis. The incidence of these tumors is gradually increasing in many countries. Recent advances have been made in identifying some of the risk factors, and the need for appropriate classification is emerging. The diagnosis of cholangiocarcinoma is often difficult and requires multiple complementary studies. The use of molecular approaches may improve the diagnostic utility of biliary cytology. Treatment of these tumors is complex, and there are many different treatment options. Although surgical resection can be curative, many patients with cholangiocarcinoma are diagnosed at an advanced stage when only palliative approaches can be used. Photodynamic therapy is emerging as a useful modality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510032     DOI: 10.1007/s11894-006-0061-1

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  50 in total

1.  The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures.

Authors:  R J Farrell; A K Jain; S L Brandwein; H Wang; R Chuttani; D K Pleskow
Journal:  Gastrointest Endosc       Date:  2001-11       Impact factor: 9.427

2.  The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

Authors:  A H Patel; D M Harnois; G G Klee; N F LaRusso; G J Gores
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

3.  Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma.

Authors:  K M McMasters; T M Tuttle; S D Leach; T Rich; K R Cleary; D B Evans; S A Curley
Journal:  Am J Surg       Date:  1997-12       Impact factor: 2.565

Review 4.  Hilar cholangiocarcinoma: a review and commentary.

Authors:  R S Chamberlain; L H Blumgart
Journal:  Ann Surg Oncol       Date:  2000 Jan-Feb       Impact factor: 5.344

5.  Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.

Authors:  J K Ramage; A Donaghy; J M Farrant; R Iorns; R Williams
Journal:  Gastroenterology       Date:  1995-03       Impact factor: 22.682

Review 6.  Magnetic resonance imaging of cholangiocarcinoma.

Authors:  Riccardo Manfredi; Brunella Barbaro; Gabriele Masselli; Amorino Vecchioli; Pasquale Marano
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

7.  Liver transplantation for unresectable perihilar cholangiocarcinoma.

Authors:  Julie K Heimbach; Gregory J Gores; Michael G Haddock; Steven R Alberts; Scott L Nyberg; Michael B Ishitani; Charles B Rosen
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

8.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

9.  Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma.

Authors:  Christopher D Anderson; Michael H Rice; C Wright Pinson; William C Chapman; Ravi S Chari; Dominique Delbeke
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

10.  Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.

Authors:  H A Pitt; A Nakeeb; R A Abrams; J Coleman; S Piantadosi; C J Yeo; K D Lillemore; J L Cameron
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

View more
  16 in total

1.  Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma.

Authors:  Xiao-Fang Liu; Hao Zhang; Shi-Guang Zhu; Xian-Ting Zhou; Hai-Long Su; Zheng Xu; Shao-Jun Li
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

Review 2.  Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy.

Authors:  Domenico Viterbo; Valerie Gausman; Tamas Gonda
Journal:  World J Gastrointest Endosc       Date:  2016-02-10

3.  A case of distal extrahepatic cholangiocarcinoma with two positive resection margins.

Authors:  Wayne A Warner; Wesley Ramcharan; Dave Harnanan; Srikanth Umakanthan; Ravi Maharaj
Journal:  Oncol Lett       Date:  2016-09-22       Impact factor: 2.967

4.  Slug inhibition upregulates radiation-induced PUMA activity leading to apoptosis in cholangiocarcinomas.

Authors:  Kejun Zhang; Bingyuan Zhang; Yun Lu; Chuandong Sun; Wei Zhao; Xuelong Jiao; Jilin Hu; Peng Mu; Hai Lu; Changyong Zhou
Journal:  Med Oncol       Date:  2010-12-01       Impact factor: 3.064

5.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.

Authors:  Yasuni Nakanuma; Yasunori Sato; Kenichi Harada; Motoko Sasaki; Jing Xu; Hiroko Ikeda
Journal:  World J Hepatol       Date:  2010-12-27

6.  Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies.

Authors:  Ioannis Hatzaras; Carl Schmidt; Peter Muscarella; W Scott Melvin; E Christopher Ellison; Mark Bloomston
Journal:  HPB (Oxford)       Date:  2010-03       Impact factor: 3.647

7.  The risk factors and diagnosis of cholangiocarcinoma.

Authors:  Christopher A Wadsworth; Adrian Lim; Simon D Taylor-Robinson; Shahid A Khan
Journal:  Hepatol Int       Date:  2012-11-10       Impact factor: 6.047

8.  Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma.

Authors:  Andreas Weber; Claus von Weyhern; Falko Fend; Jochen Schneider; Bruno Neu; Alexander Meining; Hans Weidenbach; Roland M Schmid; Christian Prinz
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

9.  Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.

Authors:  Jongha Park; Myung-Hwan Kim; Kyu-Pyo Kim; Do Hyun Park; Sung-Hoon Moon; Tae Jun Song; Junbum Eum; Sang Soo Lee; Dong Wan Seo; Sung Koo Lee
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

10.  Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.

Authors:  Chantragan Srisomsap; Phannee Sawangareetrakul; Pantipa Subhasitanont; Daranee Chokchaichamnankit; Khajeelak Chiablaem; Vaharabhongsa Bhudhisawasdi; Sopit Wongkham; Jisnuson Svasti
Journal:  J Biomed Biotechnol       Date:  2009-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.